Affiliation:
1. San Francisco Department of Public Health, San Francisco, California
Abstract
ABSTRACT
A human immunodeficiency virus type 1 (HIV-1)/HIV-2 antibody screening assay, the Genetic Systems HIV-1/HIV-2 PLUS O EIA, was compared to several established screening or confirmatory tests using an acute HIV seroconversion panel. The HIV-1/HIV-2 PLUS O EIA showed an improved sensitivity over all tested antibody screening methods, and detected antibody in 7 of 19 specimens found to be negative by a first-generation EIA but positive for the presence of HIV RNA.
Publisher
American Society for Microbiology
Reference15 articles.
1. Association of Public Health Laboratories. 2005. HIV diagnostic testing utilization survey report. Association of Public Health Laboratories Washington D.C.
2. Sensitivity of HIV-antibody assays determined by seroconversion panels
3. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type I infection. N. Engl. J. Med.324:961-964.
4. Dynamics of HIV viremia and antibody seroconversion in plasma donors
5. George, J. R., M. Rayfield, S. Philips, W. L. Heyward, J. W. Krebs, K. Odehouri, R. Soudre, K. M. De Cock, and G. Schochetman. 1990. Efficacies of U.S. Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2. AIDS4:321-326.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献